methylprednisolone hemisuccinate has been researched along with triamcinolone acetonide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosen, M; Swai, EA | 1 |
Dahl, MV; Jacob, HS; Swanson, DL | 1 |
Connor, TB; Dev, S; Eastwood, D; George, V; Han, DP; Levin, DS; Mieler, WF; Wirostko, WJ | 1 |
Chang, CH; Huang, TL; Lin, KH; Sheu, MM; Tsai, RK | 1 |
4 other study(ies) available for methylprednisolone hemisuccinate and triamcinolone acetonide
Article | Year |
---|---|
An attempt to develop a model to study the effects of intrathecal steroids.
Topics: Animals; Arachnoiditis; Cefoxitin; Desoxycorticosterone; Disease Models, Animal; Drug Interactions; Injections, Spinal; Male; Meningitis; Meningitis, Aseptic; Methylprednisolone; Methylprednisolone Hemisuccinate; Rats; Rats, Inbred Strains; Spinal Cord Diseases; Triamcinolone Acetonide | 1986 |
A dermatitis-eosinophilia syndrome. Treatment with methylprednisolone pulse therapy.
Topics: Adrenocorticotropic Hormone; Dermatitis; Eosinophilia; Humans; Hydrocortisone; Insect Bites and Stings; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Skin; Syndrome; Triamcinolone Acetonide; Wasps | 1984 |
Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation.
Topics: Adult; Aged; Aged, 80 and over; Connective Tissue; Contraindications; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Methylprednisolone Hemisuccinate; Middle Aged; Ocular Hypertension; Recurrence; Retrospective Studies; Risk Factors; Triamcinolone; Triamcinolone Acetonide | 2002 |
Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats.
Topics: Administration, Topical; Animals; Blotting, Western; Cell Count; Ectodysplasins; Evoked Potentials, Visual; Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; In Situ Nick-End Labeling; Injections, Intraperitoneal; Methylprednisolone Hemisuccinate; Nerve Crush; Nerve Degeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Proto-Oncogene Proteins c-akt; Rats; Retinal Ganglion Cells; STAT3 Transcription Factor; Triamcinolone Acetonide | 2011 |